| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/28/2001 | US6280727 Hemostatic composition comprising thrombin and microfibrillar collagen in aqueous medium |
| 08/28/2001 | US6280726 Used in treating bacterial infections |
| 08/28/2001 | US6280724 Composition and method for preserving progenitor cells |
| 08/28/2001 | CA2317003A1 Gene expression potentiator |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2178487C Local delivery of fibrinolysis enhancing agents |
| 08/28/2001 | CA2173872C Telomerase activity assays |
| 08/28/2001 | CA2096112C Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 08/28/2001 | CA2079902C Antibody conjugates for treatment of neoplastic disease |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/28/2001 | CA1341286C Blood substitutes |
| 08/25/2001 | CA2337923A1 Peptide antibiotics |
| 08/24/2001 | CA2337588A1 Oxamides as impdh inhibitors |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061019A2 A dominant selectable marker for gene transformation and disruption in yeasts |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061005A2 Molecules of the pyrin domain protein family and uses thereof |
| 08/23/2001 | WO2001061002A1 Control of membrane traffic |
| 08/23/2001 | WO2001061001A2 Novel, central nervous protein, that modulates k+ flows |
| 08/23/2001 | WO2001060998A2 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060990A2 Sphingosine kinases |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |
| 08/23/2001 | WO2001060973A2 C/ebpbeta isoforms and methods of use in cell regulation and anti-tumorigenesis |
| 08/23/2001 | WO2001060922A1 Process for the preparation of micronised collagen, and its therapeutic applications |
| 08/23/2001 | WO2001060865A2 Novel proteins and nucleic acids encoding same |
| 08/23/2001 | WO2001060864A2 Human ion channels |
| 08/23/2001 | WO2001060863A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | WO2001060862A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | WO2001060859A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060856A2 Vmglom gene and its mutations causing disorders with a vascular component |
| 08/23/2001 | WO2001060855A1 A novel human cell cycle control-related protein and a sequence encoding the same |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060848A2 Conjugates targeted to target receptors |
| 08/23/2001 | WO2001060846A1 Cyclic hexapeptide derivatives |
| 08/23/2001 | WO2001060845A1 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060843A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | WO2001060837A2 Polypeptoid pulmonary surfactants |
| 08/23/2001 | WO2001060813A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | WO2001060794A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 08/23/2001 | WO2001060784A1 Aniline-derived ligands for the thyroid receptor |
| 08/23/2001 | WO2001060420A1 A medicinal aerosol formulation |
| 08/23/2001 | WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060411A1 Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance |
| 08/23/2001 | WO2001060401A1 Methods of modulating protease-activated receptor-4 (par4) activation via cathepsin g |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060399A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/23/2001 | WO2001060398A1 Drugs for ameliorating impaired glucose tolerance |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060396A2 Method for treating thyroid disorders |
| 08/23/2001 | WO2001060395A2 Methods of treatment for non-invasive fungus-induced mucositis with cyclohexapeptide antifungal agents |
| 08/23/2001 | WO2001060394A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | WO2001060393A1 Selective destruction of cells infected with human immunodeficiency virus |
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060391A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | WO2001060384A1 Inhibition of mal-1, the keratinocyte lipid binding protein |
| 08/23/2001 | WO2001060377A2 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 08/23/2001 | WO2001060357A1 New use |
| 08/23/2001 | WO2001060351A2 Nitroacridine/tumor inhibitor compositions |
| 08/23/2001 | WO2001060341A1 Powder formulation |
| 08/23/2001 | WO2001060339A2 Method for the preparation of microspheres which contain colloidal systems |
| 08/23/2001 | WO2001060320A2 TREATMENT OF INFLAMMATION WITH p20 |
| 08/23/2001 | WO2001060317A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 08/23/2001 | WO2001060315A2 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | WO2001060162A2 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/23/2001 | WO2001060152A2 Transgenic non-human ucp2 knockout mammal |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001023522A3 Compositions and methods for p53-mediated repression of gene expression |
| 08/23/2001 | WO2001023521A3 Polypeptide derivatives of parathyroid hormone (PTH) |
| 08/23/2001 | WO2001022989A3 Method to enhance healing of sternum after sternotomy |
| 08/23/2001 | WO2001019858A3 A family of ubiquitin-like proteins binds the atpase domain of hsp70-like stch |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001011031A3 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 08/23/2001 | WO2001011012A3 Human melanoma H11 gene polynucleotides, polypeptides, and methods of use |
| 08/23/2001 | WO2001010907A3 Therapeutic polypeptides and methods for using same |
| 08/23/2001 | WO2001010892A3 Peptide antagonists of factor VIIA |
| 08/23/2001 | WO2001010387A3 Antiviral therapy use of P-glycoprotein modulators |
| 08/23/2001 | WO2001009341A3 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 08/23/2001 | WO2001007631A3 Novel glycosyltransferase, the production thereof and its use |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001000860A3 Prolactin-inducible mammary specific promoter |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000074634A3 Methods and compositions for modulating cell proliferation and cell death |
| 08/23/2001 | WO2000011965A3 Ingestible compositions comprising antibacterial agents |
| 08/23/2001 | WO2000000615A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016650 A specific polynucleotide comprising the nucleotide sequence of protein coding sequence of clone AK647 deposited under ATCC 98026; administering to a mammal an antibody reacted to the protein for promoting smooth muscle cell growth |